Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: Neuronal selectivity and potential neuroprotective role of HAP1

Human Molecular Genetics

Volumn 14, Issue 2, 2005, Pages 179-189

  Zucker, Birgit ^a   Luthi Carter, Ruth ^a   Kama, Jibrin A ^a   Dunah, Anthone W ^a   Stern, Edward A ^a   Fox, Jonathan H ^a   Standaert, David G ^a   Young, Anne B ^a   Augood, Sarah J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; CALCIUM ION; GLUTAMATE RECEPTOR; HUNTINGTIN; HUNTINGTIN ASSOCIATED PROTEIN 1; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN HAP1; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CALCIUM SIGNALING; CELL POPULATION; CELL SELECTION; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GENETIC SELECTION; HUNTINGTON CHOREA; INTERNEURON; LASER CAPTURE MICRODISSECTION; MALE; MOUSE; NERVE DEGENERATION; NERVE PROJECTION; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRIATE CORTEX; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; DISEASE MODELS, ANIMAL; HUNTINGTON DISEASE; INTERNEURONS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; NERVE TISSUE PROTEINS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; RECEPTORS, N-METHYL-D-ASPARTATE; TRANSCRIPTION, GENETIC;

EID: 12744279625     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi014     Document Type: Article

References (78)

1. Ross, C.A. (2002) Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron, 35, 819-822.
2. Vonsattel, J.P. and DiFiglia, M. (1998) Huntington disease. J. Neuropathol. Exp. Neurol., 57, 369-384.
3. Landwehrmeyer, G.B., McNeil, S.M., Dure, L.S.t., Ge, P., Aizawa, H., Huang, Q., Ambrose, C.M., Duyao, M.P., Bird, E.D., Bonilla, E. et al. (1995) Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals. Ann. Neurol. 37, 218-230.
4. Young, A.B. (2003) Huntingtin in health and disease. J. Clin. Invest., 111, 299-302.
5. Albin, R.L., Young, A.B. and Penney, J.B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci., 12, 366-375.
6. Albin, R.L. (1995) Selective neurodegeneration in Huntington's disease. Ann. Neurol., 38, 835-836.
7. Kawaguchi, Y., Wilson, C.J., Augood, S.J. and Emson, P.C. (1995) Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci., 18, 527-535.
8. Reiner, A., Albin, R.L., Anderson, K.D., D'Amato, C.J., Penney, J.B. and Young, A.B. (1988) Differential loss of striatal projection neurons in Huntington disease. Proc. Natl Acad. Sci. USA 85, 5733-5737.
9. Hirsch, E.C., Graybiel, A.M., Hersh, L.B., Duyckaerts, C. and Agid, Y. (1989) Striosomes and extrastriosomal matrix contain different amounts of immunoreactive choline acetyltransferase in the human striatum. Neurosci. Lett., 96, 145-150.
10. Harrington, K.M. and Kowall, N.W. (1991) Parvalbumin immunoreactive neurons resist degeneration in Huntington's Disease striatum. J Neuropath. Exp. Neurol., 50, 309.
11. Cicchetti, F., Gould, P.V. and Parent, A. (1996) Sparing of striatal neurons coexpressing calretinin and substance P (NK1) receptor in Huntington's disease. Brain Res., 730, 232-237.
12. Ferrante, R.J., Kowall, N.W., Beal, M.F., Richardson, E.P., Jr, Bird, E.D. and Martin, J.B. (1985) Selective sparing of a class of striatal neurons in Huntington's disease. Science, 230, 561-563.
13. Dawbarn, D., De Quidt, M.E. and Emson, P.C. (1985) Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease. Brain Res., 340, 251-260.
14. Albin, R.L., Reiner, A., Anderson, K.D., Penney, J.B. and Young, A.B. (1990) Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Ann. Neurol., 27, 357-365.
15. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W. et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell, 87, 493-506.
16. Meade, C.A., Deng, Y.P., Fusco, F.R., Del Mar, N., Hersch, S., Goldowitz, D. and Reiner, A. (2002) Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice. J. Comp. Neurol., 449, 241-269.
17. Augood, S.J., Faull, R.L., Love, DR. and Emson, P.C. (1996) Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study. Neuroscience, 72, 1023-1036.
18. Augood, S.J., Faull, R.L. and Emson, P.C. (1997) Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease. Ann. Neurol., 42, 215-221.
19. Cha, J.H., Frey, A.S., Alsdorf, S.A., Kerner, J.A., Kosinski, C.M., Mangiarini, L., Penney, J.B., Jr., Davies, S.W., Bates, G.P. and Young, A.B. (1999) Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 354, 981-989.
20. Cha, J.H., Kosinski, C.M., Kerner, J.A., Alsdorf, S.A., Mangiarini, L., Davies, S.W., Penney, J.B., Bates, G.P. and Young, A.B. (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc. Natl Acad. Sci. USA, 95, 6480-6485.
21. Luthi-Carter, R., Strand, A., Peters, N.L., Solano, S.M., Hollingsworth, Z.R., Menon, A.S., Frey, A.S., Spektor, B.S., Penney, E.B., Schilling, G. et al. (2000) Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet., 9, 1259-1271.
22. Luthi-Carter, R., Hanson, S.A., Strand, A.D., Bergstrom, D.A., Chun, W., Peters, N.L., Woods, A.M., Chan, E.Y., Kooperberg, C., Krainc, D. et al. (2002) Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum. Mol. Genet., 11, 1911-1926.
23. Beal, M.F., Kowall, N.W., Ellison, D.W., Mazurek, M.F., Swartz, K.J. and Martin, J.B. (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature, 321, 168-171.
24. Koh, J.Y., Peters, S. and Choi, D.W. (1986) Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity. Science, 234, 73-76.
25. Ellerby, L.M. (2002) Hunting for excitement: NMDA receptors in Huntington's disease. Neuron, 33, 841-842.
26. Greengard, P., Allen, P.B. and Nairn, A.C. (1999) Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23, 435-447.
27. Surmeier, D.J., Song, W.J. and Yan, Z. (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J. Neurosci., 16, 6579-6591.
28. Burgoyne, R.D. and Weiss, J.L. (2001) The neuronal calcium sensor family of Ca2+-binding proteins. Biochem. J., 353, 1-12.
29. Lariviere, R.C. and Julien, J.P. (2004) Functions of intermediate filaments in neuronal development and disease. J. Neurobiol., 58, 131-148.
30. Zijlstra, M., Bix, M., Simister, N.E., Loring, J.M., Raulet,D.H. and Jaenisch, R. (1990) Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature, 344, 742-746.
31. Bi, W.L., Keller-McGandy, C., Standaert, D.G. and Augood, S.J. (2002) Identification of nitric oxide synthase neurons for laser capture microdissection and mRNA quantification. Biotechniques, 33, 1274-1283.
32. Augood, S.J., McGowan, E.M. and Emson, P.C. (1994) Expression of N-methyl-D-aspartate receptor subunit NR1 messenger RNA by identified striatal somatostatin cells. Neuroscience, 59, 7-12.
33. Landwehrmeyer, G.B., Standaert, D.G., Testa, C.M., Penney, J.B., Jr. and Young, A.B. (1995) NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J Neurosci., 15, 5297-5307.
34. Standaert, D.G., Friberg, I.K., Landwehrmeyer, G.B., Young, A.B. and Penney, J.B., Jr. (1999) Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat. Brain Res. Mol. Brain Res., 64, 11-23.
35. Monyer, H., Burnashev, N., Laurie, D.J., Sakmann, B. and Seeburg, P.H. (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron, 12, 529-540.
36. Standaert, D.G., Landwehrmeyer, G.B., Kerner, J.A., Penney, J.B., Jr. and Young, A.B. (1996) Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus. Brain Res. Mol. Brain Res., 42, 89-102.
37. Brenman, J.E., Chao, D.S., Gee, S.H., McGee, A.W., Craven, S.E., Santillano, D.R., Wu, Z., Huang, F., Xia, H., Peters, M.F. et al. (1996) Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha 1-syntrophin mediated by PDZ domains. Cell, 84, 757-767.
38. Kornau, H.C., Schenker, L.T., Kennedy, M.B. and Seeburg, P.H. (1995) Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science, 269, 1737-1740.
39. Gines, S., Ivanova, E., Seong, I.S., Saura, C.A. and MacDonald, M.E. (2003) Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells. J. Biol. Chem., 278, 50514-50522.
40. Freeman, W. and Morton, A.J. (2004) Differential messenger RNA expression of complexins in mouse brain. Brain Res. Bull., 63, 33-44.
41. Reim, K., Mansour, M., Varoqueaux, F., McMahon, H.T., Sudhof, T.C., Brose, N. and Rosenmund, C. (2001) Complexins regulate a late step in Ca2+-dependent neurotransmitter release. Cell, 104, 71-81.
42. Berridge, M.J. (1998) Neuronal calcium signaling. Neuron 21, 13-26.
43. Tang, T.S., Tu, H., Chan, E.Y., Maximov, A., Wang, Z., Wellington, C.L., Hayden, M.R. and Bezprozvanny, I. (2003) Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor typ. 1. Neuron, 39, 227-239.
44. Dunah, A.W., Yasuda, R.P., Wang, Y.H., Luo, J., Davila-Garcia, M., Gbadegesin, M., Vicini, S. and Wolfe, B.B. (1996) Regional and ontogenic expression of the NMDA receptor subunit NR2D protein in rat brain using a subunit-specific antibody. J. Neurochem. 67, 2335-2345.
45. Ginsberg, S.D., Elarova, I., Ruben, M., Tan, F., Counts, S.E., Eberwine, J.H., Trojanowski, J.Q., Hemby, S.E., Mufson, E.J. and Che, S. (2004) Single-cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders. Neurochem. Res., 29, 1053-1064.
46. Polacek, D.C., Passerini, A.G., Shi, C., Francesco, N.M., Manduchi, E., Grant, G.R., Powell, S., Bischof, H., Winkler, H., Stoeckert, C.J., Jr. et al. (2003) Fidelity and enhanced sensitivity of differential transcription profiles following linear amplification of nanogram amounts of endothelial mRNA. Physiol. Genomics, 13, 147-156.
47. Cha, J.H. (2000) Transcriptional dysregulation in Huntington's disease. Trends Neurosci., 23, 387-392.
48. Luthi-Carter, R. and Cha, J.-H.J. (2003) Mechanisms of transcriptional dysregulation in Huntington's disease. Clinical Neuroscience Research, 3, 165-177.
49. Deckel, A.W. (2001) Nitric oxide and nitric oxide synthase in Huntington's disease. J. Neurosci. Res., 64, 99-107.
50. Norris, P.J., Waldvogel, H.J., Faull, R.L., Love, D.R. and Emson, P.C. (1996) Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease. Neuroscience, 72, 1037-1047.
51. Saur, D., Seidler, B., Paehge, H., Schusdziarra, V. and Allescher, H.D. (2002) Complex regulation of human neuronal nitric-oxide synthase exon 1c gene transcription. Essential role of Sp and ZNF family members of transcription factors. J. Biol. Chem., 277, 25798-25814.
52. Bachir, L.K., Garrel, G., Lozach, A., Laverriere, J.N. and Counis, R. (2003) The rat pituitary promoter of the neuronal nitric oxide synthase gene contains an Sp1-, LIM homeodomain-dependent enhancer and a distinct bipartite gonadotropin-releasing hormone-responsive region. Endocrinology, 144, 3995-4007.
53. Dunah, A.W., Jeong, H., Griffin, A., Kim, Y.M., Standaert, D.G., Hersch, S.M., Mouradian, M.M., Young, A.B., Tanese, N. and Krainc, D. (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science, 296, 2238-2243.
54. Li, S.H., Cheng, A.L., Zhou, H., Lam, S., Rao, M., Li, H. and Li, X.J. (2002) Interaction of Huntington disease protein with transcriptional activator Sp1. Mol. Cell. Biol., 22, 1277-1287.
55. Levine, M.S., Klapstein, G.J., Koppel, A., Gruen, E., Cepeda, C., Vargas, M.E., Jokel, E.S., Carpenter, E.M., Zarjani, H., Hurst, R.S. et al. (1999) Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. J. Neurosci. Res., 58, 515-532.
56. Cepeda, C., Ariano, M.A., Calvert, C.R., Flores-Hernandez, J., Chandler, S.H., Leavitt, B.R., Hayden, M.R. and Levine, M.S. (2001) NMDA receptor function in mouse models of Huntington disease. J. Neurosci. Res., 66, 525-539.
57. Hansson, O., Guatteo, E., Mercuri, N.B., Bernardi, G., Li, X.J., Castilho, R.F. and Brundin, P. (2001) Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene. Eur. J. Neurosci., 14, 1492-1504.
58. Sun, Y., Savanenin, A., Reddy, P.H. and Liu, Y.F. (2001) Polyglutamine-expanded huntingtin promotes sensitization of N methyl-D-aspartatereceptors via post-synaptic density 95. J. Biol. Chem., 276, 24713-24718.
59. Zeron, M.M., Hansson, O., Chen, N., Wellington, C.L., Leavitt, B.R., Brundin, P., Hayden, M.R. and Raymond, L.A. (2002) Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron, 33, 849-860.
60. Misra, C., Brickley, S.G., Wyllie, D.J. and Cull-Candy, S.G. (2000) Slow deactivation kinetics of NMDA receptors containing NR1 and NR2D subunits in rat cerebellar Purkinje cells. J. Physiol., 525 (Pt 2), 299-305.
61. Vicini, S. and Rumbaugh, G. (2000) A slow NMDA channel: in search of a role. J. Physiol., 525 (Pt 2), 283.
62. Li, X.J., Li, S.H., Sharp, A.H., Nucifora, F.C., Jr., Schilling, G., Lanahan, A., Worley, P., Snyder, S.H. and Ross, C.A. (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature, 378, 398-402.
63. Li, S.H., Yu, Z.X., Li, C.L., Nguyen, H.P., Zhou, Y.X., Deng, C. and Li, X.J. (2003) Lack of humingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease. J. Neurosci., 23, 6956-6964.
64. Shilo, B.Z. (2003) Signaling by the Drosophila epidermal growth factor receptor pathway during development. Exp. Cell Res., 284, 140-149.
65. Sibilia, M., Steinbach, J.P., Stingl, L., Aguzzi, A. and Wagner, E.F. (1998) A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor. Embo J., 17, 719-731.
66. Li, X.J., Sharp, A.H., Li, S.H., Dawson, T.M., Snyder, S.H. and Ross, C.A. (1996) Huntingtin-associated protein (HAP1): discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase. Proc. Natl Acad. Sci. USA, 93, 4839-4844.
67. Sheng, M. and Kim, M.J. (2002) Postsynaptic signaling and plasticity mechanisms. Science, 298, 776-780.
68. Augustine, G.J., Santamaria, F. and Tanaka, K. (2003) Local calcium signaling in neurons. Neuron, 40, 331-346.
69. Sheng, M., Cummings, J., Roldan, L.A., Jan, Y.N. and Jan, L.Y. (1994) Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature, 368, 144-147.
70. Dunah, A.W., Luo, J., Wang, Y.H., Yasuda, R.P. and Wolfe, B.B. (1998) Subunit composition of N-methyl-D-aspartate receptors in the central nervous system that contain the NR2D subunit. Mol. Pharmacol., 53, 429-437.
71. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
72. Ferrante, R.J., Kubilus, J.K., Lee, J., Ryu, H., Beesen, A., Zucker, B., Smith, K., Kowall, N.W., Ratan, R.R., Luthi-Carter, R. et al. (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J. Neurosci., 23, 9418-9427.
73. Littell, R.C., Milliken, G.A., Stroup, W.W. and Wolfinger, R.D. (1996) SAS System for Mixed Models. SAS Institute Inc., Cary, NC, USA.
74. Sokal, R.R. and Rohlf, F.J. (1995) Biometry, 3rd ed. W.H. Freeman, New York, USA.
75. Lei, S.Z., Pan, Z.H., Aggarwal, S.K., Chen, H.S., Hartman, J., Sucher, N.J. and Lipton, S.A. (1992) Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron, 8, 1087-1099.
76. Choi, Y.B., Tenneti, L., Le, D.A., Ortiz, J., Bai, G., Chen, H.S. and Lipton, S.A. (2000) Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat. Neurosci., 3, 15-21.
77. Ahern, G.P., Klyachko, V.A. and Jackson, M.B. (2002) cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. Trends Neurosci., 25, 510-517.
78. Kumar, U. (2004) Characterization of striatal cultures with the effect of QUIN and NMDA. Neurosci. Res., 49, 29-38.